Virtual meeting
Via Zoom
Description
As part of the twice-monthly SUD Care Continuum ECHO® series, Roger Weiss, MD, will develop interdisciplinary approaches to shared decision-making and care coordination when patients consider tapering or discontinuing medications for opioid use disorder (MOUD), and describe current evidence, risks, and clinical considerations related to continuing, tapering, or discontinuing MOUD. He will also apply patient-centered, evidence-informed strategies to support patients who choose to taper or discontinue MOUD, including risk mitigation and ongoing follow-up. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
The Substance Use Disorder Care Continuum ECHO® (SUD Care Continuum ECHO®) series offers training and support in addiction treatment, with a focus on supporting front line addiction treatment workforce. This includes health providers in Acute Treatment Services (ATS), Crisis Stabilization Services (CSS), Transitional Support Services (TSS), Opioid Treatment Programs (OTP), long-term residential program, sober and recovery homes, primary care, and psychiatry. This free, case-based tele-mentoring program is designed to increase the capacity of health care providers to implement high-quality and evidence-based addiction treatment.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Roger Weiss, MD
Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, including for developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site treatment study of prescription opioid dependence. He has authored over 300 publications, including several books, and was vice chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders.
Objectives
Following this training, participants will have the knowledge to:
1. Develop interdisciplinary approaches to shared decision-making and care coordination when patients consider tapering or discontinuing medications for opioid use disorder (MOUD).
2. Describe current evidence, risks, and clinical considerations related to continuing, tapering, or discontinuing MOUD.
3. Apply patient-centered, evidence-informed strategies to support patients who choose to taper or discontinue MOUD, including risk mitigation and ongoing follow-up.
Sponsored by
Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Accreditation information
Please read the Accreditation Information section of the training registration page for accreditation details and to learn about the requirements for receiving credit or a certificate of completion.
